These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7706304)

  • 1. Characterization of apolipoprotein J-Alzheimer's A beta interaction.
    Matsubara E; Frangione B; Ghiso J
    J Biol Chem; 1995 Mar; 270(13):7563-7. PubMed ID: 7706304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein J and Alzheimer's amyloid beta solubility.
    Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
    Ghiso J; Matsubara E; Koudinov A; Choi-Miura NH; Tomita M; Wisniewski T; Frangione B
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):27-30. PubMed ID: 8328966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
    Zlokovic BV
    Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
    Zlokovic BV; Martel CL; Matsubara E; McComb JG; Zheng G; McCluskey RT; Frangione B; Ghiso J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4229-34. PubMed ID: 8633046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.
    Hammad SM; Ranganathan S; Loukinova E; Twal WO; Argraves WS
    J Biol Chem; 1997 Jul; 272(30):18644-9. PubMed ID: 9228033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.
    Golabek A; Marques MA; Lalowski M; Wisniewski T
    Neurosci Lett; 1995 May; 191(1-2):79-82. PubMed ID: 7659297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.
    Koudinov A; Matsubara E; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1164-71. PubMed ID: 7802646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural properties of lipid-associated apolipoprotein J (clusterin).
    Calero M; Tokuda T; Rostagno A; Kumar A; Zlokovic B; Frangione B; Ghiso J
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):375-83. PubMed ID: 10567218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle.
    Xu Q; Li Y; Cyras C; Sanan DA; Cordell B
    J Biol Chem; 2000 Oct; 275(41):31770-7. PubMed ID: 10918055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.
    Oda T; Wals P; Osterburg HH; Johnson SA; Pasinetti GM; Morgan TE; Rozovsky I; Stine WB; Snyder SW; Holzman TF
    Exp Neurol; 1995 Nov; 136(1):22-31. PubMed ID: 7589331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells.
    Reddy KB; Jin G; Karode MC; Harmony JA; Howe PH
    Biochemistry; 1996 May; 35(19):6157-63. PubMed ID: 8634259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
    Reddy KB; Karode MC; Harmony AK; Howe PH
    Biochemistry; 1996 Jan; 35(1):309-14. PubMed ID: 8555189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin.
    Kounnas MZ; Loukinova EB; Stefansson S; Harmony JA; Brewer BH; Strickland DK; Argraves WS
    J Biol Chem; 1995 Jun; 270(22):13070-5. PubMed ID: 7768901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro.
    Xie Z; Harris-White ME; Wals PA; Frautschy SA; Finch CE; Morgan TE
    J Neurochem; 2005 May; 93(4):1038-46. PubMed ID: 15857407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of apolipoprotein J.
    de Silva HV; Stuart WD; Park YB; Mao SJ; Gil CM; Wetterau JR; Busch SJ; Harmony JA
    J Biol Chem; 1990 Aug; 265(24):14292-7. PubMed ID: 2387851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations.
    Shayo M; McLay RN; Kastin AJ; Banks WA
    Life Sci; 1997; 60(7):PL115-8. PubMed ID: 9042383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.
    Nishida K; Quantock AJ; Dota A; Choi-Miura NH; Kinoshita S
    Br J Ophthalmol; 1999 Oct; 83(10):1178-82. PubMed ID: 10502582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.